bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2023,
Volume and Issue:
unknown
Published: Dec. 12, 2023
Abstract
Background
Hyperglycemia
and
hyperlipidemia
lead
to
the
ferroptosis,
well
as
phosphorylation
of
Erbb4,
thereby
increase
risk
cardiac
hypertrophy.
Thus,
our
investigation
aims
explore
whether
vitamin
D
could
mitigate
diabetic
injury
through
modulation
Erbb4/ferroptosis
axis.
Methods
results
KKAy
mice
fed
on
a
high-fat
diet
were
utilized
construct
prediabetic
model,
which
showed
an
up-regulated
with
concurrent
ferroptosis
in
tissues.
Following
intervention
for
16
weeks,
activity
Erbb4/YAP
signaling
was
suppressed
severeness
improved.
Meanwhile
disturbances
glucose-lipid
metabolism
insulin
secretion
induced
by
high
fat
alleviated,
along
improvements
hypertrophy
myocardial
function.
Moreover,
we
established
vitro
damage
model
introducing
H9c2
cells
glucose
(HG,
33.3
mM)
palmitic
acid
(PA,
0.25
mM).
Unsurprisingly,
similar
have
been
acquired
after
supplementation.
Subsequently,
selective
inhibitors
Erbb4
(Dacomitinib)
(Ferrostatin-1)
applied
evaluate
efficiency
modulating
,
conclusively
confirming
that
inhibiting
indeed
reduce
under
HG
PA
stimulus.
Additionally,
treatment
found
cardiomyocyte
prevent
cell
death
activity.
Interestingly,
combined
Vitamin
Dacomitinib
exerted
synergistic
effect
ameliorating
abnormal
conditions.
Conclusions
Our
study
unveils,
correlation
between
heart.
Providing
evidences
supplementation
can
improve
related
inactivation
Erbb4.
Proposing
combination
may
emerge
highly
feasible
clinical
strategy
injury.
Current Pharmaceutical Design,
Journal Year:
2024,
Volume and Issue:
30(5), P. 323 - 332
Published: Feb. 1, 2024
Abstract:
Neuroinflammation
represents
a
critical
immune
response
within
the
brain,
playing
pivotal
role
in
defense
against
injury
and
infection.
However,
when
this
becomes
chronic,
it
can
contribute
to
development
of
various
neurodegenerative
psychiatric
disorders.
This
bibliographic
review
delves
into
vitamin
D
modulating
neuroinflammation
its
implications
for
brain
health,
particularly
context
neurological
While
is
traditionally
associated
with
calcium
homeostasis
bone
also
exerts
immunomodulatory
neuroprotective
effects
central
nervous
system.
Through
comprehensive
analysis
preclinical
clinical
studies,
we
uncover
how
D,
acting
through
receptors
glial
cells,
may
influence
production
proinflammatory
cytokines
antioxidants,
potentially
mitigating
cascade
events
leading
neuronal
damage.
Clinical
research
has
identified
deficiency
as
common
thread
increased
risks
multiple
sclerosis,
Parkinson's
disease,
Alzheimer's,
depression,
among
others.
Furthermore,
models
suggest
D's
regulatory
capacity
over
inflammatory
mediators,
protective
apoptosis,
contribution
neurogenesis
synaptic
plasticity.
These
insights
underscore
potential
supplementation
not
only
slowing
progression
diseases
but
improving
quality
life
patients
suffering
from
conditions.
Future
studies
are
essential
validate
these
findings
further
our
understanding
prevent
or
alleviate
symptoms,
opening
new
avenues
therapeutic
strategies
neuroinflammation-related
pathologies.
crucial
injuries
infections,
persistence
lead
such
Parkinson's,
depression.
Cholecalciferol
(Vitamin
D3)
emerges
regulator
neuroinflammation,
present
cells
astrocytes
microglia,
function.
Vitamin
mechanisms
action
include
cytokine
modulation
regulation
nuclear
mitochondrial
genes.
It
adjusts
mediators
resulting
effects.
Additionally,
impacts
neurotransmitter
synthesis
positions
adjunct
treating
like
Alzheimer's
Parkinson's.
Lastly,
intestinal
microbiota
serotonin
contributes
disorders
schizophrenia
Thus,
presents
novel
approach
neuroinflammatory,
neurodegenerative,
neuropsychiatric
diseases.
Frontiers in Pharmacology,
Journal Year:
2025,
Volume and Issue:
16
Published: Jan. 31, 2025
Neuronal
senescence
is
a
common
pathological
feature
of
various
neurodegenerative
diseases,
with
ferroptosis
playing
significant
role.
This
study
aims
to
investigate
the
role
ErbB4
receptor
activation
in
preventing
D-Galactose
(D-gal)-induced
neuronal
senescence.
Mice
subjected
D-gal-induced
aging
were
administered
small
molecule
agonist
(E4A),
identified
via
virtual
screening,
melatonin,
or
combination
both.
Behavioral
assessments
conducted
evaluate
therapeutic
efficacy
memory
and
cognitive
functions.
Immunofluorescence
staining,
western
blot,
biochemical
assays
primarily
employed
assess
changes
both
senescence-
ferroptosis-related
molecules
mouse
hippocampal
tissues
response
each
treatment.
Additionally,
HT22
cell
cultures
utilized
corroborate
vivo
findings.
The
targeted
by
E4A
significantly
ameliorated
behavioral
deficits
induced
D-gal
mice,
demonstrating
an
effect
comparable
that
natural
inhibitor
ferroptosis.
Both
melatonin
mitigated
neurons
mice.
was
evidenced
upregulation
Lamin
B1
downregulation
P53,
P21,
P16,
GFAP,
Iba-1
expression
levels.
Moreover,
treatment
markedly
decreased
protein
Nrf2
while
augmenting
promoter
TFRC.
These
alterations
partially
reversed
individual
administration
melatonin.
In
vitro
studies
further
corroborated
concurrently
markers
promoters.
However,
able
reverse
these
changes.
Erastin-induced
cells.
Our
findings
suggest
may
be
viable
strategy
for
treating
inhibiting
ferroptosis,
thereby
offering
potential
avenue
senescence-associated
diseases.
The Journal of Steroid Biochemistry and Molecular Biology,
Journal Year:
2025,
Volume and Issue:
249, P. 106710 - 106710
Published: Feb. 20, 2025
The
interaction
between
vitamin
D
and
the
immune
system
is
perhaps
most
well
recognised
extraskeletal
facet
of
D,
encompassing
early
studies
therapy
for
TB
leprosy
through
to
more
recent
links
with
autoimmune
disease.
However,
spotlight
on
function
has
been
particularly
intense
in
last
five
years
following
COVID-19
pandemic.
This
was
due,
part,
many
association
status
infection
disease
prognosis,
as
smaller
number
clinical
trials
supplementation.
a
potential
role
also
stemmed
from
basic
biology
that
provides
plausible
mechanistic
rationale
beneficial
effects
improved
health
setting
respiratory
infection.
aim
this
review
summarise
different
strands
evidence
supporting
effect
COVID-19,
how
modified
during
pandemic
itself,
new
aspects
are
likely
arise
near
future.
Key
topics
feature
are:
antibacterial
versus
antiviral
innate
responses
1,25-dihydroxyvitamin
(1,25(OH)2D);
1α-hydroxylase
(CYP27B1)
activity
metabolism
25-hydroxyvitamin
(25(OH)D)
beyond
antigen-presenting
cells;
advances
cell
target
gene
(notably
changes
metabolic
profile).
Whilst
much
interest
era
focused
public
health,
continued
evolution
our
understanding
interacts
components
continues
support
health.
Journal of Biological Chemistry,
Journal Year:
2024,
Volume and Issue:
300(8), P. 107583 - 107583
Published: July 16, 2024
Ferroptosis
is
an
iron-dependent
cell
death
mechanism
that
may
be
important
to
prevent
tumor
formation
and
useful
as
a
target
for
new
cancer
therapies.
Transcriptional
networks
play
crucial
role
in
shaping
ferroptosis
sensitivity
by
regulating
the
expression
of
transporters,
metabolic
enzymes,
other
proteins.
The
Cap'n'collar
(CNC)
protein
nuclear
factor
erythroid
2
like
(NFE2L2,
also
known
NRF2)
key
regulator
many
cells
contexts.
Emerging
evidence
indicates
related
CNC
family
members
BTB
homology
1
(BACH1)
(NFE2L1)
have
non-redundant
roles
regulation.
Here,
we
comprehensively
review
transcription
factors
governing
cellular
ferroptosis.
We
describe
how
regulate
through
modulation
iron,
lipid,
redox
metabolism.
use
examples
regulation
proteins
illustrate
flexible
highly
context-dependent
nature
between
conditions.
Frontiers in Cell and Developmental Biology,
Journal Year:
2025,
Volume and Issue:
13
Published: March 21, 2025
Ferroptosis,
a
non-apoptotic,
iron-dependent
form
of
regulated
cell
death,
is
closely
related
to
the
pathogenesis
neurodegenerative
diseases.
Stem
cells
and
their
derivatives
exhibit
remarkable
potential
in
modulating
ferroptosis,
offering
promising
therapeutic
intervention
for
In
this
review,
we
systematically
explore
neurological
aging
its
association
with
cognitive
impairment
diseases,
focus
on
molecular
mechanisms
ferroptosis
diseases
strategies
stem
ABSTRACT
Aims
Neuropathic
pain
remains
a
significant
unmet
medical
challenge
due
to
its
elusive
mechanisms.
Recent
clinical
observations
suggest
that
vitamin
D
(VitD)
holds
promise
in
relief,
yet
precise
mechanism
of
action
is
still
unclear.
This
study
explores
the
therapeutical
role
and
potential
VitD
3
spared
nerve
injury
(SNI)‐induced
neuropathic
rat
model.
Methods
The
analgesic
effects
underlying
mechanisms
were
evaluated
SNI
naïve
models.
Mechanical
allodynia
was
assessed
using
Von
Frey
test.
Western
blotting,
immunofluorescence,
biochemical
assay,
transmission
electron
microscope
(TEM)
employed
investigate
molecular
cellular
.
Results
Ferroptosis
observed
spinal
cord
following
SNI.
Intrathecal
administration
,
active
form
VitD,
activated
receptor
(VDR),
suppressed
ferroptosis,
alleviated
mechanical
nociceptive
behaviors.
treatment
preserved
GABAergic
interneurons,
neuroprotective
eliminated
by
ferroptosis
inducer
RSL3.
Additionally,
mitigated
aberrant
mitochondrial
morphology
oxidative
metabolism
cord.
Mechanistically,
inhibited
SNI‐induced
activation
PKCα/NOX4
signaling.
Inhibition
signaling
hypersensitivity,
accompanied
reduced
dysfunction
rats.
Conversely,
rats
induced
hyperalgesia,
loss
cord,
all
which
reversed
treatment.
Conclusions
Our
findings
provide
evidence
attenuates
preserving
interneurons
through
suppression
mitochondria‐associated
mediated
signaling,
probably
via
VDR
activation.
alone
or
combination
with
existing
analgesics,
presents
an
innovative
therapeutic
avenue
for
pain.